TITLE

ORTHOVITA'S CORTOSS SYNTHETIC BONE FILLER MORE EFFECTIVE

PUB. DATE
March 2003
SOURCE
Worldwide Biotech;Mar2003, Vol. 15 Issue 3, p3
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Focuses on clinical studies which examined the efficacy of CORTOSS Synthetic Cortical Bone Void Filler, a biomaterial designed to replace and reinforce bone in the spine weakened by osteoporosis and metastatic disease, from Orthovita Inc.
ACCESSION #
9213192

 

Related Articles

  • Deals roundup.  // Medical Device Daily;10/22/2007, Vol. 11 Issue 202, p6 

    The article reports that spine and orthopedic biosurgery company Orthovita will be acquiring raw material, equipment and a technology license from Allergan for about $6.6 million. A payment in a lump sum is expected to be made by Orthovita on or before October 31, 2007. Orthovita is a developer...

  • ORTHOVITA GETS NANO-PARTICLE STRUCTURED TECHNOLOGY PATENT.  // Worldwide Biotech;Mar2002, Vol. 14 Issue 3, p6 

    Reports on the patent received by Orthovita Inc. on its nano-structured technology

  • ORTHOVITA SELLS BIOGRAN DENTAL LINE TO IMPLANT INNOVATIONS.  // Biotech Equipment Update;May2000, p5 

    Focuses on issues related to Orthovita Inc. in Malvern, Pennsylvania. Sale of Biogran dental grafting product line to Implant Innovations Inc.; Use of sale proceeds to enhance working capital for the commercialization of CORTOSS and VITOSS products; Reason for increase in 1999 net losses of...

  • ORTHOVITA COMPLETES RHAKOSS PILOT CLINICAL STUDY IN EUROPE.  // Worldwide Biotech;Oct2002, Vol. 14 Issue 10, p2 

    Reports that Orthovita Inc. has completed the initial clinical pilot study in Europe for RHAKOSS Synthetic Bone Spinal Implant.

  • Stockholders aim to block Stryker, Orthovita merger.  // Medical Device Daily;6/2/2011, Vol. 15 Issue 106, p3 

    The article reports on the plan of Orthovita stockholders to stop the 316 million U.S. dollars merger of the company with Stryker, which according to a lawsuit filed by the shareholders breaches the fiduciary duty of Orthovita.

  • Nature inspire technology.  // Futurist;May/Jun95, Vol. 29 Issue 3, p7 

    Reports that researchers are increasingly looking at biological materials as inspiration for new man-made materials. Potential applications of biomaterials; Contact information.

  • AdvaMed: 'major oversight' in biocomp draft.  // Medical Device Daily;7/30/2013, Vol. 17 Issue 145, p7 

    The article reports that the Advanced Medical Technology Association (AdvaMed) offered comments on July 22, 2013 about the draft guidance for biocompatibility testing proposed by the U.S. Food and Drug Administration (FDA). AdvaMed commented that the FDA draft guideline places a very strong...

  • Biomaterials in the 21st century? Katz, J. Lawrence // Journal of Rehabilitation Research & Development;Oct95, Vol. 32 Issue 3, pVii 

    Editorial. Comments on the future of biomaterials industry. Range of appropriate materials to choose from; Area of limb prostheses; Bases for future innovations in biomaterials design and use setting.

  • European perspectives on biomaterials for health. Donnelly, Fergal // EWMA Journal;Apr2015, Vol. 15 Issue 1, p54 

    Biomaterials for health will become a major focus of European research efforts in the coming years and as part of the Horizon 2020 Framework Programme for Research and Innovation. They will find applications particularly as integral parts of Advanced Therapy Medicinal Products (ATMPs) or,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics